Application 213931

Type
NDA
Sponsor
ARDELYX INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001XPHOZAHTENAPANOR HYDROCHLORIDETABLET;ORALEQ 10MG BASEYesNo
002XPHOZAHTENAPANOR HYDROCHLORIDETABLET;ORALEQ 20MG BASEYesNo
003XPHOZAHTENAPANOR HYDROCHLORIDETABLET;ORALEQ 30MG BASEYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82591SUPPL 2025-06-17
82587SUPPL 2025-06-17
81715SUPPL 2025-03-25
81704SUPPL 2025-03-24
79581ORIG 2024-09-12
75856ORIG 2023-10-19
75837ORIG 2023-10-18